Allena Pharmaceuticals (ALNA) Short Interest Ratio & Short Volume

Short interest is the volume of Allena Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 10,340,000 shares of ALNA short. Learn More on Allena Pharmaceuticals' current short interest.

Allena Pharmaceuticals saw a decline in short interest in August. As of August 15th, there was short interest totaling 10,340,000 shares, a decline of 21.7% from the previous total of 13,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Allena Pharmaceuticals: Genocea Biosciences, Inc. (0.33%), Eloxx Pharmaceuticals, Inc. (0.08%), Amgen Inc. (2.41%), Gilead Sciences, Inc. (1.69%), argenx SE (3.56%), BioNTech SE (2.20%), Biogen Inc. (2.60%), Neurocrine Biosciences, Inc. (4.26%), Exelixis, Inc. (7.05%), Qiagen (2.96%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power, Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks.

Short selling ALNA is an investing strategy that aims to generate trading profit from Allena Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Allena Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALNA, twice per month. The most recent reporting period available is August, 15 2022.